Status:
TERMINATED
Observing Pelvic Organ Prolapse Symptoms And Treatment Outcomes
Lead Sponsor:
Melissa Fischer, MD
Collaborating Sponsors:
Corewell Health East
Conditions:
Genital Prolapse
Eligibility:
FEMALE
21+ years
Brief Summary
To prospectively observe the outcomes of surgical prolapse treatment in terms of urinary, bowel, and sexual function, quality of life, patient satisfaction, cost, and achieving patient determined trea...
Detailed Description
Patients meeting the inclusion/exclusion criteria will be identified by reviewing the hospital's surgical boarding list and contacted by phone to obtain informed consent. Once informed consent is obta...
Eligibility Criteria
Inclusion
- Female
- Pelvic Organ Prolapse
- Able to provide informed consent
- Able to complete study assessments, per clinician judgment
Exclusion
- Age \< 21 years
- Currently pregnant or \< 6 months post-partum
Key Trial Info
Start Date :
October 29 2008
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 29 2016
Estimated Enrollment :
301 Patients enrolled
Trial Details
Trial ID
NCT00784602
Start Date
October 29 2008
End Date
August 29 2016
Last Update
January 3 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
William Beaumont Hospital
Royal Oak, Michigan, United States, 48073